Plexus Corp (NASDAQ: PLXS) closed at $295.02 on Friday, registering a new 52-week high as the electronic manufacturing services provider benefited from accelerating reshoring demand from defence, healthcare, and industrial OEM customers.
Key Highlights
- PLXS stock gained 2.46% on Friday to close at $295.02, a new 52-week high on volume of approximately 221,000 shares.
- Trailing diluted EPS of $6.84 supports a P/E of 43.12, reflecting market pricing of sustained revenue growth from high-complexity electronics manufacturing contracts.
Plexus Corp stock has been a steady beneficiary of the US industrial policy shift toward domestic electronics manufacturing. The company's specialisation in low-to-medium volume, high-complexity programmes across regulated industries gives it a differentiated market position that commodity EMS competitors cannot easily replicate.
With a market cap approaching $7.9 billion, PLXS is the largest name in the specialty EMS category. Its customer concentration in defence and aerospace, medical devices, and industrial technology means revenue is less cyclical than broad-based contract manufacturers, a characteristic that justifies a premium valuation multiple.
For investors evaluating whether Plexus stock is a buy after its new 52-week high, the reshoring investment case remains compelling. US government procurement requirements increasingly mandate domestic manufacturing content, a structural tailwind that should sustain Plexus order books for multiple years.
Electronic manufacturing services stocks have broadly re-rated higher in 2026 as supply chain security became a national priority. Among EMS stocks to watch in 2026, PLXS stands out for its focus on mission-critical applications where price is secondary to reliability and compliance.
This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.






Please wait processing your request...